In a previous paper we showed that bradykinin (BK), interacting with its B 2 receptor, inhibits proximal tubule Na + -ATPase activity but does not change (Na + + K + )ATPase activity. The aim of this paper was to investigate the molecular mechanisms involved in B 2 -mediated modulation of proximal tubule Na + -ATPase by BK. To abolish B 1 receptor-mediated effects, all experiments were carried out in the presence of (Arg-Pro-ProGly-Phe-Ser-Pro-Leu), des-Arg 9 -[Leu 8 ]-BK (DALBK), a specific antagonist of B 1 receptor. A dual effect on the Na + -ATPase activity through the B 2 receptor was found: short incubation times (1-10 min) stimulate the enzyme activity; long incubation times (10-60 min) inhibit it. The stimulatory effect of BK is mediated by activation of phosphoinositide-specific phospholipase C β (PI-PLCβ)/protein kinase C (PKC); its inhibitory action is mediated by Ca 2+ -independent phospholipase A 2 (iPLA 2 ). Prior activation of the PI-PLCβ/PKC pathway is required to activate the iPLA 2 -mediated inhibitory phase. These results reveal a new mechanism by which BK can modulate renal sodium excretion: coupling between B 2 receptor and activation of membrane-associated iPLA 2 .
Introduction
Bradykinin (BK) is a component of the kallikrein-kinin system and plays an important role in electrolyte balance as well as blood pressure regulation [1] . These effects are associated with the modulation of renal sodium excretion and are due, at least in part, to modulation of transcellular sodium reabsorption [2] . Because most filtered sodium is reabsorbed in proximal tubules, small changes in this process will have major consequences for the overall sodium metabolism in the body. Furthermore, the pathologies correlated to renal sodium excretion, such as primary hypertension, have been associated with changes in proximal tubule sodium reabsorption [3] .
The limiting step for sodium reabsorption in the proximal tubule is its active basolateral transport through the primary active transporters [4] . Two primary active transporters involved in the genesis of the Na + electrochemical gradient have been described: ouabain-sensitive (Na + + K + )ATPase and ouabain-insensitive, furosemide-sensitive Na + -ATPase [5] [6] [7] . In a previous paper our group showed that BK inhibits proximal tubule Na + -ATPase activity through B 2 receptors but does not change the (Na + + K + )ATPase activity [8] . This inhibitory effect of BK on proximal tubule Na + -ATPase activity is compatible with B 2 -mediated natriuresis and diuresis [9] .
The effects of BK are mediated by two types of kinin receptors: B 1 and B 2 [10, 11] . Normally, B 2 receptors are constitutively expressed in tissues; B 1 is expressed only in specific situations. Both receptors have seven transmembrane domains and belong to the family of G protein-coupled receptors. Previous studies indicate that the B 2 -mediated bradykinin effects on renal sodium excretion are, at least in part, mediated by activation of phospholipase A 2 (PLA 2 ) [12] . However, the type of PLA 2 and the molecular mechanism underlying the coupling among bradykinin receptor, PLA 2 activity and active sodium transporters are still to be determined. There are three classes of PLA 2 , based on the Ca 2+ requirement for enzymatic activity: secretory PLA 2 (sPLA 2 ), which requires millimolar concentrations of Ca 2+ ; cytosolic PLA 2 (cPLA 2 ), which requires micromolar concentrations of Ca 2+ ; and Ca 2+ -independent PLA 2 (iPLA 2 ) [13] . So far nothing is known about the regulation of iPLA 2 by peptide hormones, in particular BK.
The aim of this study was to test the involvement of membraneassociated iPLA 2 on the B 2 -mediated BK inhibition of proximal tubule Na + -ATPase activity. To avoid the PLA 2 present in the cytosol fraction we used basolateral membranes (BLM) isolated from porcine proximal tubule cells. This preparation contains components of different signaling pathways including G proteins, phospholipases and protein kinases [14] [15] [16] . Interestingly, it was observed that BK at the B 2 receptor has a dual effect on the Na + -ATPase activity that is mediated by sequential activation of the membrane-associated phosphoinositide-specific phospholipase C β (PI-PLCβ)/protein kinase C (PKC) and iPLA 2 pathways. These results reveal an additional mechanism by which BK can modulate renal sodium excretion: coupling between B 2 receptor and membrane-associated iPLA 2 activation.
Materials and methods

Materials
ATP, ouabain, furosemide, EGTA, HEPES, Tris, bradykinin (Arg-Pro-ProGly-Phe-Ser-Pro-Phe-Arg), des-Arg
]-BK (DALBK), diclofenac sodium salt, indomethacin, and 1,2-dipalmitoyl-phosphatidylcholine (DPPC) were purchased from Sigma Chemical Co., St. Louis, MO, USA. Percoll was from Pharmacia Biotech, Uppsala, Sweden. Palmitoyl trifluoromethyl ketone (PACOCF 3 ), N-(p-amylcinnamoyl) anthranilic acid (ACA) and quinacrine dihydrochloride (Mepacrine) were purchased from Calbiochem-Novabiochem Co., San Diego, CA, USA. Rabbit polyclonal antibody anti-iPLA 2 was purchased from Upstate Biotechnology, Lake Placid, NY, USA and peroxidaseconjugated sheep anti-rabbit antibody was purchased from Calbiochem, San Diego, CA, USA. All other reagents were of the highest purity available. [ 
Isolated basolateral membranes
The basolateral membranes (BLM) of proximal tubules were isolated and purified using the Percoll gradient method as described previously [18] . The membrane preparation was resuspended in 250 mM sucrose at a final concentration of 5-10 mg protein/ml and stored at − 20°C. The (Na + + K + )ATPase activity, a marker for basolateral membranes, was 10-12 times higher than the activity found in the cortex. Residual contamination with other subcellular membrane fractions was minimal. Protein concentration was determined by the Folin phenol method [19] using bovine serum albumin as a standard.
Measurement of ATPase activity
The composition of the assay medium for the measurement of the Na + -ATPase activity (0.1 ml) was: 4 mM MgCl 2 ; 4 mM ATP (specific activity about 10 4 Bq/nmol ATP); 20 mM HEPES-Tris (pH 7.0); 90 mM NaCl; 10 − 8 M DALBK; and 1 mM ouabain. The ATPase activity was measured according to the method described by Grubmeyer and Penefsky [20] . The reaction was started by the addition of the membranes to the assay medium to a final protein concentration of 0.3-0.5 mg/ml, and stopped after 10 min by the addition of 0.1 N HCl-activated charcoal. The [ 
Measurement of PLA 2 activity
The PLA 2 activity was measured according to the method described by Yang et al. [22] . The assay utilized 100 μM DPPC (containing 5.0 × 10 5 cpm of L-3-phosphatidylcholine, 1-palmitoyl-2-[1- 
Measurement of PKC activity
The PKC activity of isolated BLM was measured by calphostin C (Cph C)-sensitive incorporation of 32 Pi from [γ 32 -P]ATP (7 μCi/μmol), using histone as substrate. The composition of the reaction medium was: 4 mM MgCl 2 , 20 mM HEPES-Tris (pH 7.0), 1.5 mg/ml histone and 0.7 mg/ml protein. The reaction was stopped with 40% TCA and the sample immediately placed on ice. An aliquot (0.1 ml) was filtered through a Millipore filter (0.45 μm) and washed with ice-cold 20% TCA solution and 0.1 M phosphate buffer (pH 7.0). The radioactivity was quantified by liquid scintillation counting (Packard Tri-Carb 2100 TR). The specific PKC activity was calculated from the difference between the activity in the absence and in the presence of 10 − 8 M Cph C. The phorbol ester, phorbol myristate acetate (PMA), was used as the activator of PKC.
Immunoblotting
The presence in basolateral membranes of iPLA 2 protein was determined by immunoblotting. Proteins were resolved on 7.5% SDS-PAGE gels and transferred to nitrocellulose membranes (Amersham Biosciences, Piscataway, NJ, USA) according to the manufacturer's instructions. The membranes were incubated overnight with the anti-iPLA 2 antibody 1:500 with agitation at 4°C, washed three times and then incubated with anti-rabbit peroxidase-conjugated antibody (Amersham Pharmacia) diluted 1:5000 in PBST plus 3% non-fat dry milk for 1 h at room temperature, with agitation. After antibody labeling, detection was performed with ECL (Amersham Biosciences, Piscataway, NJ, USA).
Data analysis
The means were compared by one-way variance analysis (ANOVA) taking into account the treatment of the experimental groups. The magnitudes of the differences were evaluated using the multiple comparative Bonferroni test. The data are presented as the mean ± standard error. The n corresponds to the results obtained from different basolateral membrane preparations.
Results
In a previous paper we showed that BK has a biphasic effect on proximal tubule Na + -ATPase activity, with an inhibitory effect mediated by B 2 receptor and a stimulatory effect mediated by B 1 receptor [8] . Here we examined the possibility that the B 2 -mediated inhibition of the Na + -ATPase by BK could be mediated by activation of PLA 2 . All experiments were carried out in the presence of 10 − 8 M DALBK, a specific antagonist of B 1 receptor that completely abolishes the B 1 -mediated stimulation of enzyme activity by BK [24] . The pre-incubation of the enzyme with 10 − 9 M BK for 30 min decreased Na + -ATPase activity from 27.5 ± 3.1 to 13.9 ± 2.5 nmol Pi × mg − 1 × min − 1 (Fig. 1A) . This effect was completely abolished by the PLA 2 non-specific inhibitors, quinacrine and ACA, at 10 − 8 M. Since all experiments were done in the absence of added Ca 2+ and in the presence of 1 mM EGTA, this result indicates the involvement of Ca 2+ -independent PLA 2 (iPLA 2 ) in the BK effect. To test this hypothesis, the experiments were performed in the presence of PACOCF 3 and bromoenol lactone (BEL), specific inhibitors of iPLA 2 [25] (Fig. 1B) . PACOCF 3 and BEL at 10 − 6 M completely reversed the inhibitory effect of BK 10 − 9 M on Na + -ATPase activity. Quinacrine, ACA, BEL and PACOCF 3 at 10 − 6 M did not affect Na + -ATPase activity when added separately, without BK (data not shown).
To determine the presence of iPLA 2 in BLM we measured its activity directly (Fig. 2) . The isolated BLM were incubated with 10 − 9 M BK for different times (1, 3, 5, 10, 20 and 30 min). After the reaction, the phospholipids were separated and PLA 2 activity was quantified. Fig. 2A shows the effect of 10 − 9 M BK on PLA 2 activity. BK increased PLA 2 activity by 120% with the maximal effect observed at 5 min. This was completely reversed after 20 min of incubation. To further confirm the presence of iPLA 2 in BLM, immunoblotting using rabbit anti-iPLA 2 antibody was carried out (Fig. 2B) . A band at 85 kDa which corresponds to the correct molecular mass for iPLA 2 [26] was detected in cortex homogenate and BLM. Rat cerebellum was used as a positive control for iPLA 2 [27] . The correlation between the effect of BK on Na + -ATPase activity and activation of iPLA 2 was tested in the next experimental group (Fig. 2C) . The BK-stimulated PLA 2 activity was completely reversed by PACOCF 3 and BEL at 10 − 6 M, specific inhibitors of iPLA 2 (Fig. 2C) . Furthermore, it was observed that both PACOCF 3 and BEL completely abolished the basal PLA 2 activity (data not shown).
B 2 receptor belongs to the G protein-coupled receptor family, and consequently, is associated with trimeric G proteins [11] . To confirm that the effect of 10 − 9 M BK on the BLM-associated iPLA 2 is mediated by B 2 receptor, we performed experiments in the presence of 10 − 6 M HOE140, a specific antagonist for B 2 , and 10 − 6 M GDPβS, a non-hydrolyzable GDP analog that inhibits trimeric G proteins (Fig. 2C) . Both compounds completely abolished the stimulatory effect of BK on the BLMassociated iPLA 2 activity. Similarly, these compounds abolished the inhibitory effect of 10 − 9 M BK on Na + -ATPase activity (data not shown).
It is well known that PLA 2 catalyzes the hydrolysis of the sn-2 position of membrane glycerophospholipids to liberate arachidonic acid (AA) [13] . The increase in concentration of AA from (Fig. 2D) . This effect is similar and non-additive to the BK effect. Fig. 3 shows the modulation of the effect of 10 − 9 M BK or 10 − 8 M AA on Na + -ATPase activity by the cyclooxygenase (COX) inhibitors, 10 − 9 M diclofenac and 10 − 6 M indomethacin. It was observed that the inhibitory effect of BK or AA was completely reversed by both COX inhibitors. The addition of diclofenac or indomethacin alone did not change the Na + -ATPase activity (data not shown).
These data indicate that a membrane-associated, Ca 2+ -independent PLA 2 isoform is involved in the inhibitory effect of BK on Na + -ATPase activity. Fig. 4A shows the effect of BK on Na + -ATPase activity in the presence of 10 − 8 M DALBK, a specific antagonist of B 1 receptor. BK at 10 − 9 M had a dual effect on Na + -ATPase activity. The incubation of the enzyme with 10 − 9 M BK for a short time (1-10 min) increased Na + -ATPase activity, with a maximal effect observed at 1 min. After 15 min of incubation, 10 − 9 M BK inhibited the enzyme activity with a maximal effect observed at 30 min. This inhibitory effect was maintained for at least 60 min (data not shown). To be sure that the stimulatory effect is mediated by B 2 receptor, we tested the effect of 10 − 6 M HOE140, a specific antagonist for B 2 (Fig. 4B) . Under these conditions, we observed that the stimulatory effect of 10 − 9 M BK observed after the incubation of the enzyme for 1 min was completely abolished. These data show that interaction of BK with B 2 receptor activates different pathways. Recently, we showed that the activation of the PI-PLCβ/PKC pathway leads to activation of proximal tubule Na + -ATPase activity [15] . Fig. 4B shows the effect of 10 − 9 M BK on Na + -ATPase activity during 1 min of incubation with 10 − 8 M Cph C, an inhibitor of PKC, and 5 × 10 − 8 M U73122, a specific inhibitor of PI-PLCβ. Both compounds completely abolished the stimulatory effect of BK. Fig. 5 shows the effect of 10 − 9 M BK on PI-PLCβ and PKC activities in BLM. BK increased both enzyme activities after a short period of incubation. The maximal effect for PI-PLCβ was observed at 30 s (Fig. 5A) and for PKC at 3 min (Fig. 5B) , The next experiments were carried out to study the requirement for prior activation of the PI-PLCβ/PKC pathway on PLA 2 -mediated inhibition of the Na + -ATPase by 10 − 9 M BK after 30 min of incubation (Fig. 6A) . The inhibitory effect of 10 − 9 M BK was reversed by 10 − 8 M Cph C and 5 × 10 − 8 M U73122 when these were added before BK. On the other hand, the addition of 10 − 8 M Cph C or 5 × 10 − 8 M U73122 after 15 min of incubation with BK, when activation of the PI-PLCβ/ PKC pathway was complete, did not change the inhibitory effect of BK on the enzyme activity. Fig. 6B shows the modulation of BK-stimulated iPLA 2 activity by an agonist and two antagonists of the PI-PLCβ/PKC pathway. BK (10 − 9 M) increased iPLA 2 activity, and this effect was completely abolished by 10 − 8 M Cph C or 5 × 10 − 8 M U73122. Furthermore, 10 − 12 M phorbol ester (PMA), an activator of PKC, increased iPLA 2 activity in a similar manner to BK.
These data show that activation of the PI-PLCβ/PKC pathway is a critical step prior to Ca 2+ -independent, membraneassociated iPLA 2 -mediated inhibition of Na + -ATPase by BK.
Discussion
In this paper we show that BK, through its B 2 receptor, has a dual effect on proximal tubule Na + -ATPase in a time-dependent manner. Previously, it was shown that BK could have opposite effects depending on the receptor with which it interacts [28] . Two receptors coupled to GTP binding protein have been described for BK: B 1 and B 2 [29] . In a previous paper we showed that BK, via its B 1 receptor, increases proximal tubule Na + -ATPase activity, and inhibits this activity through its B 2 receptor [8] . However, the possible involvement of the B 1 receptor in the time-dependent dual effect of BK on proximal tubule Na + -ATPase can be ruled out because: (1) all experiments were carried out in the presence of 10 − 8 M DALBK, a specific antagonist of B 1 receptor that completely abolishes the B 1 -mediated stimulation of enzyme activity by BK; and (2) HOE140, a specific antagonist for B 2 receptor, abolished both time-dependent stimulatory and inhibitory effects of BK on the enzyme activity.
Furosemide is also well characterized to inhibit the Na + /K + / 2Cl − cotransporter. However, the effect of furosemide observed in the present work cannot be associated with the inhibition of this cotransporter because: (a) this cotransporter is not able to hydrolyze ATP; (b) this cotransporter is not present in the proximal tubule; and (c) the cotransporter phosphorylated form has a molecular weight of 170 kDa; the molecular weight of the Na + -stimulated, furosemide-sensitive ATP driven E-P is 100 kDa [30] . Na + -ATPase belongs to the P-type ATPase family and several studies have shown biochemical differences between this enzyme and the classical (Na + K + )ATPase [6] [7] [8] 30, 31] . This enzyme is completely inhibited by furosemide but is insensitive to ouabain, a classic (Na + + K + )ATPase inhibitor. The possible effect of furosemide in other ATPases can also be ruled out because it was observed that furosemide does not change the (Na + + K + )ATPase, Mg 2+ -ATPase, Ca 2+ -ATPase and EctoATPase activities [7, 32] . So, it is plausible to postulate that furosemide, in the preparation used in the present manuscript, works as a "specific inhibitor" of Na + -ATPase. We also observed that bradykinin has the same effect on Na + -ATPase measured by Na + stimulation in the presence of ouabain 1 mM. The link between Na + -stimulated ATPase activity and Na + transport was also shown by Malnic et al. [33] . They observed that furosemide inhibits Na + reabsorption in the proximal tubule. It has been demonstrated that ouabain-insensitive Na + -ATPase is a primary active transporter target for compounds that are involved in the regulation of renal Na + excretion, such as the peptides of the kallikrein-kinin system [10, 15, [34] [35] [36] . Na + -ATPase is about 10 times less active than (Na + + K + )ATPase [31] , which suggests that this enzyme may be involved in fine tuning, whereas (Na + + K + )ATPase is responsible for most of the Na + reabsorption in the proximal tubule. The data reported in the present paper, together with observations reported by our group in previous papers, indicate that Na + -ATPase is involved, at least in part, in the effect of BK on proximal tubule sodium reabsorption [8, 10, 36] . In addition, because B 2 receptor mediates a dual effect of BK on Na + -ATPase, we postulate that this effect may permit fine tuning of sodium reabsorption in proximal tubules.
The mechanisms involved in the modulation of sodium reabsorption in proximal tubule cells by BK are still to be determined [2, 9] . The results obtained in this paper show that: (a) the stimulatory phase involves activation of the PI-PLCβ/PKC pathway, and the inhibitory phase involves a Ca 2+ -independent, BLM-associated PLA 2 ; (b) prior activation of the PI-PLCβ/PKC pathway is required for activation of the iPLA 2 -mediated inhibitory phase; and (c) the inhibitory effect of BK depends on the metabolism of AA by COX. These results represent a new mechanism of regulation of renal sodium excretion by BK.
In the present manuscript, we used isolated BLM which avoids the possible translocation of PLA 2 from cytosol to plasma membrane after its activation. Furthermore, all experiments were carried out in the absence of Ca 2+ . In this way, the involvement of Ca 2+ -dependent group IV cPLA 2 (α and β) can be ruled out because its activation involves Ca 2+ -dependent translocation to plasma membranes. On the other hand, cPLA 2 γ, which belongs to group IV, lacks a C2 domain (Ca 2+ -independent) and could be constitutively associated with cell membrane through a palmitoylation site. The molecular weight of cPLA 2 γ is 61 kDa; we showed the presence of only one band of 85 kDa in BLM using polyclonal antibody anti-iPLA 2 . Furthermore, the observation that PACOCF 3 and BEL abolished both basal and BK-stimulated PLA 2 activity associated with BLM could indicate the presence of group VI iPLA 2 in the proximal tubule BLM. This hypothesis is strengthened by observation that a BEL-sensitive group VI iPLA 2 with molecular weight around 85 kDa, has been shown in renal cortex [26, [37] [38] [39] [40] [41] . However, the involvement of group IV cPLA 2 γ cannot be completely ruled out. Further experiments are necessary to clarify this issue. The activation of PLA 2 could lead to either an increase or a decrease in Na + reabsorption in proximal tubule cells, depending on the agonist and the cellular distribution of PLA 2 [12, 42] . It was observed that BK modulates Ca 2+ -dependent PLA 2 activity in rabbit isolated proximal tubule; BK-stimulated cPLA 2 activity but decreased Ca 2+ -dependent, membrane-associated cPLA 2 activity [43] . On the other hand, the role of iPLA 2 is still not completely known. It was proposed that group VI iPLA 2 regulates phospholipid turnover, cell growth and apoptosis. In a previous paper, it was shown that the iPLA 2 located in endoplasmic reticulum plays an important role against oxidant-induced lipid peroxidation and oncosis in proximal tubules [38] . However, its modulation by hormones and its involvement in sodium homeostasis are yet to be determined. Here we show that BK induces the activation of BLM-associated iPLA 2 activity. These data agree with the observation that BK, via the B 2 receptor, inhibits Na + reabsorption in the proximal tubule, showing a close correlation between sodium excretion and iPLA 2 activation. This result opens up new possibilities for understanding the role of this enzyme in renal sodium excretion as well as blood pressure regulation.
The molecular mechanisms involved in the activation of iPLA 2 are poorly understood. In the present study, we observed that the inhibition of PKC (with Cph C) and PI-PLCβ (with U73122) abolished the BK-induced activation of PLA 2 . Furthermore, the phorbol ester, PMA, an activator of PKC, increased the PLA 2 activity in a similar manner to BK. Because we used isolated BLM, the presence of a membrane-associated PKC pool is required. In a previous paper, we showed that BLM has a resident pool of PKC activated by phorbol ester and insensitive to Ca 2+ [44] . In a similar way, using membrane fractions of ventricular myocytes, Steer et al. [45] showed that PMA increases iPLA 2 through activation of a resident pool of PKC. These results show that PKC is the link between the activation of PI-PLCβ and Ca 2+ -independent, membrane-associated PLA 2 by BK. However, there is a question still to be answered: does PKC mediate the activation of iPLA 2 through direct phosphorylation or is this effect mediated by another protein? Although no phosphorylation consensus sequences have been described in iPLA 2 , different studies suggest the involvement of phosphorylation in the regulation of this enzyme [37, 40, [46] [47] [48] .
In summary, we have shown that BK, through its B 2 receptor, has a dual effect on proximal tubule Na + -ATPase activity, mediated by the integrated activation of two different pathways: PI-PLCβ/PKC and iPLA 2 . These results open new possibilities in our understanding of the molecular mechanisms underlying BK regulation of renal sodium excretion and the role of iPLA 2 in this process.
